UPyTher, a spin-off company of the Eindhoven University of Technology, is a preclinical stage company and develops long-acting hydrogel-drug formulations for the treatment of peritoneal diseases – a field that comes with specific requirements when it comes to local intraperitoneal drug delivery and treatment.

The company was founded in 2020 with the vision to increase the treatment options and outcome for patients with peritoneal carcinomatosis and turn it into a treatable disease. Our mission is to set a new standard of care in peritoneal oncology by making intraperitoneal therapy simple, safe, and effective.

UPyTher

Org chart

Teams

Offices